Ductal carcinoma in situ: Management update

Australian Family Physician

Volumn 34, Issue 11, 2005, Pages 949-954

  Stuart, Kirsty ^a   Boyages, John ^a,b   Brennan, Meagan ^a   Ung, Owen ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

AXILLA; BREAST TUMOR; CALCINOSIS; FEMALE; HUMAN; LYMPHADENECTOMY; MAMMOGRAPHY; MASTECTOMY; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATIENT CARE; PRACTICE GUIDELINE; RADIOGRAPHY; RADIOTHERAPY; REVIEW; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, HORMONAL; AXILLA; BREAST NEOPLASMS; CALCINOSIS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; MAMMOGRAPHY; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; PATIENT CARE TEAM; PRACTICE GUIDELINES; RADIOTHERAPY;

EID: 33644835904     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rosen PP, Lieberman PH, Braun DW, Kosloff C, Adair F. Lobular carcinoma in situ of the breast. Am J Surg Pathol 1978;2:225-50.
2. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978;42:737-69.
3. Page DL, Dupont WD, Rogers LW, Landenberger M. Intraductal carcinoma of the breast: follow up after biopsy only. Cancer 1982;49:751-8.
4. Rosen PP, Braun DW Jr, Kinne DW. The clinical significance of preinvasive breast carcinoma. Cancer 1980;46:919-25.
5. Meyer JS. Cell kinetics of histologic variants of in situ breast carcinoma. Breast Cancer Res Treat 1986;7:171-80.
6. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197-200.
7. Delaney G, Ung O, Bilous M, Cahill S, Greenberg ML, Boyages J. Ductal carcinoma in situ. Part I: Definition and diagnosis. Aust NZ J Surg 1997;67:81-93.
8. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of non-invasive disease to frequency of occult invasion, multicentricity, lymph node metastases and short term treatment failures. Cancer 1982;50:1309-14.
9. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ. A meta-analysis. Cancer 1999;85:616-28.
10. Delaney G, Ung O, Bilous M, Cahill S, Boyages J. Ductal carcinoma in situ. Part II: Treatment. Aust NZ J Surg 1997;67:157-65.
11. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the national surgical adjuvant breast project (NSABP) eight year update of protocol B-17. Cancer 1999;86:429-38.
12. Rosner D, Bedwani RN, Vana PHJ, Barker HW, Murphy GP. Non-invasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139-47.
13. Histologic type of breast cancer. In: BreastScreen Victoria. Annual Statistics Report, 2002. Carlton South: BreastScreen Victoria, 2004;35.
14. Shugg D, White V, Kitchen P, Pruden M, Collins J, Hill D. Surgical management of ductal carcinoma in situ in Australia in 1995. Aust NZ J Surg 2002;72:708-15.
15. Evans A, Pinder S. Intraductal epithelial lesions. In: Evans A, Pinder S, Wilson R, Ellis I, editors. Breast calcification: A diagnostic manual. London: Greenwich Medical Media, 2002;Ch 2.
16. Holland R, Hendriks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
17. Holland R, Hendriks JHCL. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994;11:181-92.
18. Ashikari R, Huvos AG, Snyder RE. Prospective study of non-infiltrating carcinoma of the breast. Cancer 1997;39:435-9.
19. Sunshine JA, Moseley HS, Fletcher WS, Krippaehne WW. Breast carcinoma in situ: a retrospective review of 112 cases with a minimum 10 year follow up. Am J Surg 1985;150:44-51.
20. Farrow JH. Current concepts in the detection and the treatment of the earliest of the early breast cancers. Cancer 1970;25:468-77.
21. Recht A, Danoff BS, Solin LJ, et al. Intraductal carcinoma of the breast: results of treatment with excisional biopsy and irradiation. J Clin Oncol 1985;3:1339-43.
22. Zafrani B, Fourquet A, Vilcoq JR, Legal M, Calle R. Conservative management of intraductal breast carcinoma with tumorectomy and radiation therapy. Cancer 1986;57:1299-301.
23. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000;355:528-33.
24. UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma in situ (DCIS) Working Party. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003;362:95-102.
25. Silverstein MJ, Rosser RJ, Gierson ED, et al. Axillary lymph node dissection for intraductal breast carcinoma: is it indicated? Cancer 1987;59:1819-24.
26. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994;73:664-7.
27. Parker RG, Berkbigler D, Rees K, et al. Axillary node dissection in ductal carcinoma in situ. Am J Clin Oncol 1998;21:109-10.
28. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases and short term treatment failures. Cancer 1982;50:1309-14.
29. Pendas S, Dauway E, Giuliano R, et al. Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 2000;7:15-20.
30. Solin LJ, Fourquet A, McCormick B, et al. Salvage treatment of local recurrence following breast conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. Int J Radiat Oncol Biol Phys 1994;30:3-9.